Top Biotechnology Startups in 2026

Seed Health, Inc. is a microbial sciences company pioneering applications of bacteria to impact human and environmental health. In collaboration with leading academic partners, our foundry model accelerates breakthrough science to develop live biotherapeutics and consumer innovations. Our Scientific Advisory Board is comprised of leading scientists with expertise in microbiology, immunology, genetics, metabolomics, gastroenterology, pediatrics, environmental sciences, and women’s health. Learn more—seedhealth.com Our consumer portfolio, Seed®, develops next-generation probiotics for specific developmental stages and various ecosystems of the body—seed.com

Inquire to learn more about our platform technologies.

Ark is building the world’s highest-fidelity bioprocess simulation software to help life-saving therapies reach patients faster. By democratizing complex AI x multi-physics models in an intuitive software interface, we are transforming how bioprocess scientists work.

Ataraxis AI is a VC-backed start-up working at the intersection of multi-modal AI, oncology, and precision medicine. We are building cutting-edge diagnostic tools to assist physicians in selecting the most optimal treatments for their patients. We are a team of AI researchers, medical doctors and operators advised by a team of advisors who are pioneers in their respective fields, including the AI godfather, Yann LeCun, and oncologists at top cancer research institutes. At Ataraxis, you will have a unique opportunity to shape not just the future of our company, but the future of healthcare. We are looking to bring on highly motivated candidates to fulfill this mission.

At 4Catalyzer we strive to transform 21st century medicine by solving today’s most challenging problems – across life science research tools, medical devices and therapeutics. We aspire to create significant societal impact and are motivated by the idea that our products will change the lives of people we love. Fundamentally, we are focused on developing new types of sensors and pairing them with deep learning to get a window into biology and medicine that nobody has ever had before. We have audacious plans – but we have an unbeatable team and a founder that has disrupted biomedical science successfully more than once. If you have experience in image reconstruction, mixed-signal IC design, high-speed electronics, nanophotonics, microfabrication, MEMs, biophysics, biochemistry, molecular biology, deep learning, cloud computing, embedded systems, or hold any dual degree with distinction along with computer science please contact us and “put a dent in the universe”.

Invitae is a leader in medical genetic testing, driving genetic information into mainstream medicine to improve healthcare for billions of people. Invitae is aggregating the world's medical genetic tests into a single service with higher quality, faster turnaround time, and lower prices. By driving down the cost of genetic testing we make it affordable and accessible to everyone who can benefit. Our dedication to our mission is fueling explosive growth, with both our test volume and revenue doubling year-over-year for the past four years. Our team has grown from 300 employees to more than 1,000 in just two years and we have helped hundreds of thousands of patients get the answers they need. Why medical genetics? Within each of us lies information coded in our DNA that can transform our health. Unlocking those answers to make medicine more personalized requires highly specialized, multidisciplinary collaboration. Our platform is setting the standard for the exploding medical genetics industry by harnessing the power of advanced technologies – robotics, artificial intelligence, machine learning, software engineering – and world-class genetic expertise. We provide genetic information that guides decisions for patients facing a vast array of health questions, from ultra-rare diseases and the most common cancers to starting a family. The team driving our mission thrives in a culture designed to enable innovation at scale. We are grounded in freedom with responsibility and a universal sense of urgency and ownership. Employees are empowered to speak up, try new things and make decisions that push us forward. We provide all employees with opportunities to grow and advance, supported by flexible work hours, unlimited paid time off, the ability to work anywhere for many roles and the satisfaction of doing meaningful work. Each day at Invitae means driving forward toward a new era in which everyone can have their health decisions guided by genetics.

Volta Labs was spun out of MIT in 2018 with the simple mission of building biological automation from the ground up. Volta is in the proximity of Kendall Square, known as "the most innovative square mile on the planet". Being part of the open biotech culture in Kendall Square made us realize that today’s biologists are held back by the limitations of existing automation tools. With DNA sequencing in particular, we observed that the advances in DNA readout technologies had moved further along than the advances in the upstream steps of preparing samples for sequencing (sample prep). ‍ What started out as a simple printed circuit board to manipulate colored droplets at the MIT Media Lab during co-founder Udayan Umapathi’s graduate work was quickly directed toward solving the “sample prep bottleneck”. The company raised Seed Funding from top VCs in 2019 and later that year added Will Langford as a co-founder and Head of Engineering. ‍ Since then, we have been heads down in the lab inventing and building novel fluidic and sample manipulation technologies. We take an anti-disciplinary approach to solve very hard problems and weave together instrumentation, fluidics, software, biology and chemistry. While our current focus is on sequencing sample prep, we envision a new approach where a single universal machine automates most biological workflows in genomics, proteomics and synthetic biology.

Veeva builds enterprise cloud technology that powers the biggest names in the pharmaceutical, biotech, consumer goods, chemical & cosmetics industries. Our customers make vaccines, life-saving medicines, and life-enhancing products that make a difference in everyday lives. Our technology has transformed these industries; enabling them to get critical products and services to market faster. Our core values, Do the Right Thing, Customer Success, Employee Success, and Speed, guide us as we make our customers more efficient and effective in everything they do.

We have created a revolutionary silicon-based DNA synthesis platform, that offers precision at a scale otherwise unavailable to our customers. We provide an innovative silicon-based DNA Synthesis Platform which enables production of high-quality synthetic DNA which is faster and more affordable than ever before. Our platform allows you to work with genes, oligo pools (with CRISPR), variant libraries, DNA data storage and NGS target enrichment.

More than 40% of all fresh produce is wasted in the US, which accounts for over $17 billion dollars in lost product annually and contributes more CO2 emissions than all of US transportation combined. Globally, food that is never consumed accounts for 7% of the global freshwater supply and 308MM hectares of land. Our goal is to reduce these drastic numbers by making the produce supply chain smarter. Strella uses proprietary IoT biosensors to monitor and predict produce quality in real time as it travels the supply chain. We reduce food waste and help deliver better quality produce to consumers. Our product is used commercially in high-value decision-making in apple and pear storage. We’re growing the team to improve our product and service higher impact markets.